ELI LILLY AND COMPANY

Eli Lilly is a healthcare and pharmaceutical and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Eli Lilly has 33,815 employees as on 2019. Headquarters is in USA.

Annual Results Summary:

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Net Profit	EPS (USD)
DEC-2020	24,539	6,193
DEC-2019	22,319	8,318	8.69
DEC-2018	24,555	3,232	3.14
DEC-2017	22,871	-204 (Loss)	-0.19
DEC-2016	21,222	2,737	2.49

Balance Sheet Summary

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Year Ending:	Total Current Assets	Total Assets	Total Current Liabilities	Total Liabilities	Total Equity
Dec-2020	17,462	46,633	12,481	40,807	5,641
Dec-2019	13,710	39,286	11,775	36,587	2,607
Dec-2018	20,550	43,908	11,888	32,999	9,829
Dec-2017	19,202	44,981	14,536	33,313	11,592
Dec-2016	15,101	38,806	10,987	24,725	14,008

Quarterly Results Summary:

Eli Lilly and Company - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending	Revenue	Net Profit	EPS - USD
Sep-2020	4,414	1,208	1.54
Jun-2020	4,277	1,412	1.89
Mar-2020	5,859	1,456	1.52
Dec-2019	6,114	1,495	1.56
Sep-2019	5,476	1,253	1.31
Jun-2019	5,636	1,327	1.53
Mar-2019	5,092	4,241	4.31
Dec-2018	6,438	1,125	1.10
Sep-2018	6,061	1,149	1.11

ELI LILLY AND COMPANY

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Eli Lilly and Company - Quarterly Revenue and Net Profit - in Million USD:

Share it on Social Media